Cargando…

Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability

Treatment with HSV1716 via intralesional administration has proven successful for melanoma patients with the hope that oncolytic virotherapy would become another weapon in the systemic anticancer therapy (SACT) arsenal. In addition to challenges surrounding the systemic delivery of oncolytic viruses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howard, Faith, Conner, Joe, Danson, Sarah, Muthana, Munitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240779/ https://www.ncbi.nlm.nih.gov/pubmed/35782876 http://dx.doi.org/10.3389/fmolb.2022.889395

Ejemplares similares

HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
por: Tazzyman, Simon, et al.
Publicado: (2023)

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
por: Braidwood, Lynne, et al.
Publicado: (2014)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
por: Robilotti, Elizabeth, et al.
Publicado: (2023)

High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy
por: Sprague, Leslee, et al.
Publicado: (2018)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

HSV: The scout and assault for digestive system tumors
por: Li, Sheng, et al.
Publicado: (2023)

Genetic Modifications That Expand Oncolytic Virus Potency
por: Cristi, Francisca, et al.
Publicado: (2022)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
por: Kwan, Amy, et al.
Publicado: (2021)

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2022)

Molecular determinants of the interaction between HSV-1 glycoprotein D and heparan sulfate
por: Gandy, Lauren A., et al.
Publicado: (2022)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
por: Green-Tripp, Gabriela, et al.
Publicado: (2022)

Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements
por: Shao, Su, et al.
Publicado: (2022)

Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
por: Vannini, Andrea, et al.
Publicado: (2023)

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer
por: Nabi, Rafiq, et al.
Publicado: (2023)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products
por: Gao, Menghan, et al.
Publicado: (2022)

Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
por: Abdulal, Rwaa H., et al.
Publicado: (2023)

Influence of seasonal and geographic variation on the anti-HSV-1 properties and chlorogenic acids content of Helichrysum aureonitens Sch. Bip
por: Adeosun, Wilson Bamise, et al.
Publicado: (2022)

A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
por: Carter, Mary E., et al.
Publicado: (2022)

3-Dimensional coculture of breast cancer cell lines with adipose tissue–Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection via labeling technology
por: Salman, Marwa Ibrahim, et al.
Publicado: (2022)

Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
por: Obaid, Qayssar A., et al.
Publicado: (2022)

Network-Based Analysis Reveals Novel Biomarkers in Peripheral Blood of Patients With Preeclampsia
por: Lin, Jing, et al.
Publicado: (2022)

Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians
por: Wang, Zongyi, et al.
Publicado: (2022)

Machine learning based on metabolomics reveals potential targets and biomarkers for primary Sjogren’s syndrome
por: Wang, Kai, et al.
Publicado: (2022)

Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring
por: Qian, Yue-Tong, et al.
Publicado: (2022)

Measuring Protein Aggregation and Stability Using High-Throughput Biophysical Approaches
por: Kwan, Tristan O. C., et al.
Publicado: (2022)

Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zou, Binbin, et al.
Publicado: (2022)

An Integrated Metabolomic Screening Platform Discovers the Potential Biomarkers of Ischemic Stroke and Reveals the Protective Effect and Mechanism of Folic Acid
por: Yang, Yan-hui, et al.
Publicado: (2022)

Milk metabolomics analyses of lactating dairy cows with divergent residual feed intake reveals physiological underpinnings and novel biomarkers
por: Hailemariam, Dagnachew, et al.
Publicado: (2023)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

Plasma metabolomics by nuclear magnetic resonance reveals biomarkers and metabolic pathways associated with the control of HIV-1 infection/progression
por: Gómez-Archila, León Gabriel, et al.
Publicado: (2023)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

Imperial Spain 1469-1716 /
por: Elliott, John Huxtable
Publicado: (1963)

Westminster Hospital, 1716–1966
por: Gaskell, E.
Publicado: (1968)

Integrated Analysis of Transcriptomic and Genomic Data Reveals Blood Biomarkers With Diagnostic and Prognostic Potential in Non-small Cell Lung Cancer
por: Kaya, Ibrahim H., et al.
Publicado: (2022)

Less is more: Enterobactin concentration dependency in copper tolerance and toxicity
por: Peralta, Daiana Romina, et al.
Publicado: (2022)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

PON-All: Amino Acid Substitution Tolerance Predictor for All Organisms
por: Yang, Yang, et al.
Publicado: (2022)

Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in Staphylococcus aureus
por: Shen, Tianwei, et al.
Publicado: (2021)

Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ah7fi7049og7ansgam26us7rkk